%0 Journal Article %T Further results of the FRAGMATIC trial of thromboprophylaxis in lung cancer %A Macbeth, Fergus %A Carter, Ben %A Noble, Simon Nobl %A Hood, Kerenza %J Translational Lung Cancer Research %D 2016 %B 2016 %9 %! Further results of the FRAGMATIC trial of thromboprophylaxis in lung cancer %K %X The FRAGMATIC trial was a multi-centre, open-label study comparing the addition of a primary prophylactic daily dose of the low molecular weight heparin (LMWH), dalteparin, for 24 weeks to standard treatment in newly diagnosed lung cancer patients of any stage or histology (1). %U https://tlcr.amegroups.org/article/view/7988 %V 5 %N 3 %P 347-349 %@ 2226-4477